Clinical Trial: Efficacy and Safety Analysis of Combined MAsdupeptide Therapy in Patients with Severe Obesity (BMI > 40 kg/m²) Three Months After Laparoscopic Sleeve Gastrectomy: A Single-Arm, Prospective, Exploratory Study (China)

Posted On: 2026-08-18

China, Aug. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety Analysis of Combined MAsdupeptide Therapy in Patients with Severe Obesity (BMI > 40 kg/m²) Three Months After Laparoscopic Sleeve Gastrectomy: A Single-Arm, Prospective, Exploratory Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130221

Registration Time: 2026/08/17

Type: Interventional study

Primary Sponsor: Fuzhou University Affiliated Provincial Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337619

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Efficacy and Safety Analysis of Combined MAsdupeptide Therapy in Patients with Severe Obesity (BMI > 40 kg/m²) Three Months After Laparoscopic Sleeve Gastrectomy: A Single-Arm, Prospective, Exploratory Study (China)